Entering edit mode
9.3 years ago
andrew
▴
560
I found this site on Thomson Reuters about a consortium for Computational Biology for Drug Discovery and it's a bit obscure. I've contacted them but I think they are solely focused on big pharma. Does anyone have any additional information on this group and what things they are curating? I see they have a Phase 5, but no information about what that means.